Source: Virtual Congress 2020 – Digital health: a brave new world?



Rating:

Share or cite this content

Citations should be made in the following way:
K. Kostikas (Ioannina, Greece). Designs of future digital trials and the promise of artificial intelligence. Virtual Congress 2020 – Digital health: a brave new world?

Member's Comments

No comment yet.

Related content which might interest you: Artificial intelligence for thoracic radiology: from research tool to clinical practice Source: Eur Respir J, 57 (5) 2100625; 10.1183/13993003.00625-2021 Year: 2021 Lessons from negative dyspnoea studies: arguments for the multidimensional evaluation of multidirectional therapeutic approaches Source: Eur Respir J, 53 (1) 1802471; 10.1183/13993003.02471-2018 Year: 2019 Biologics: current use and future applications for personalised therapy Source: Virtual Congress 2021 – Wheezing illnesses along the life span Year: 2021 New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response Source: Eur Respir Rev 2014; 23: 367-378 Year: 2014 What could we learn from ongoing therapeutic trials? Source: ERS Research Seminar Year: 2015 Innovative realistic training phantom for all aspects of diagnostic and therapeutic bronchoscopy Source: Virtual Congress 2020 – Evaluation of knowledge transfer into clinical practice Year: 2020 From clinical trials to real-world data: New dimensions of patient benefits Source: International Congress 2015 – IgE-mediated asthma: New revelations and future insights Year: 2015 Digital home resources in clinical trial management Source: Virtual Congress 2021 – Digital health and innovation Year: 2021 New uses of data: from big data to artificial intelligence and clinical decision tools  in children with respiratory diseases Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases Year: 2021 Digital health: will the promise be realised? Source: International Congress 2017 – Digital health: transforming the respiratory landscape Year: 2017 From the bedside: upcoming new clinical strategies Source: International Congress 2016 – Scientific Year in Review 2016 Year: 2016 The future of translational lung cancer research: from classical randomised controlled trials to innovative platform trials Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer Year: 2018 Electronic monitoring devices in clinical trials – a doddle to use? Source: International Congress 2017 – Inhalers and their use Year: 2017 Wearable technologies in respiratory functional assessment Source: ERS webinar 2021: Wearable technologies in respiratory functional assessment Year: 2021 Value of animal models. Lessons learnt from another therapeutic area: implications for respiratory disease Source: Annual Congress 2007 - PG11 - Translation of animal models to human airway disease Year: 2007 Implications of the exposome and its applicability in clinical and epidemiological studies Source: International Congress 2016 – Genetics, epigenetics and the exposome Year: 2016 Use of machine learning to develop algorithm: advantages and limitations for clinical practice Source: Value-Dx event 2019: VALUE-Dx kick off meeting and course Year: 2019